What is Angiocrine Bioscience worth?
$25.1Mlast known valuation
Angiocrine Bioscience last raised $2.1M in its Seed Round (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Angiocrine Bioscience
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Seed Round | $2.1M | ▮ | ▮ |
| Oct 2021 | Later Stage VC | $58.1M | ▮ | ▮ |
How Angiocrine Bioscience's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Angiocrine Bioscience, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Angiocrine Bioscience worth?
- Angiocrine Bioscience's last known valuation is $25.1M.
- How much has Angiocrine Bioscience raised?
- Angiocrine Bioscience has raised $88.8M in total funding across 2 recorded rounds.
- When did Angiocrine Bioscience last raise?
- Angiocrine Bioscience last raised in Aug 2025 (Seed Round), raising $2.1M.